Key Points
- Trulieve Cannabis CEO Kim Rivers sold 137,535 shares on June 17 for a total of $1.29 million, at an average price of $9.36 per share.
- After the transaction, Rivers still directly owned 3,038,385 shares valued at about $28.44 million, and the sale represented a 4.33% reduction in her position. The trade was made under a pre-arranged Rule 10b5-1 plan.
- Trulieve shares opened at $9.21, trading well above the stock’s 52-week low of $3.25 but below its 52-week high of $13.28. Meanwhile, Weiss Ratings initiated coverage with a sell (d-) rating, matching the stock’s current consensus rating of Sell.
Trulieve Cannabis Corp. (NYSE:TRLV - Get Free Report) CEO Kim Rivers sold 137,535 shares of the business's stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $9.36, for a total transaction of $1,287,327.60. Following the completion of the sale, the chief executive officer directly owned 3,038,385 shares of the company's stock, valued at $28,439,283.60. The trade was a 4.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Stock Performance
Shares of TRLV stock opened at $9.21 on Tuesday. Trulieve Cannabis Corp. has a one year low of $3.25 and a one year high of $13.28.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings began coverage on Trulieve Cannabis in a report on Tuesday, June 16th. They set a "sell (d-)" rating on the stock. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of "Sell".
Read Our Latest Stock Report on Trulieve Cannabis
Trulieve Cannabis Company Profile
(
Get Free Report)
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve's operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
